Form 424B1 - Prospectus [Rule 424(b)(1)]:
SEC Accession No. 0001193125-17-345863
Filing Date
2017-11-17
Accepted
2017-11-16 21:30:56
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B1 d427310d424b1.htm 424B1 2548546
2 GRAPHIC g427310g13u57.jpg GRAPHIC 111203
3 GRAPHIC g427310g33a79.jpg GRAPHIC 131109
4 GRAPHIC g427310g33c79.jpg GRAPHIC 49256
5 GRAPHIC g427310g39n62.jpg GRAPHIC 77834
6 GRAPHIC g427310g52l47_color.jpg GRAPHIC 111633
7 GRAPHIC g427310g58p18.jpg GRAPHIC 97884
8 GRAPHIC g427310g59g46_color.jpg GRAPHIC 90204
9 GRAPHIC g427310g79v47.jpg GRAPHIC 49951
10 GRAPHIC g427310g87d19.jpg GRAPHIC 35704
  Complete submission text file 0001193125-17-345863.txt   3590482
Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B1 | Act: 33 | File No.: 333-221050 | Film No.: 171209598
SIC: 2836 Biological Products, (No Diagnostic Substances)